Preface on Small Cell Lung Cancer1
Preface on small cell lung cancer
Translational Lung Cancer Research
2016;
5
(1)
:1
.
(02 February 2016)
Review Article on Small Cell Lung Cancer1
Cellular and molecular biology of small cell lung cancer: an overview
Translational Lung Cancer Research
2016;
5
(1)
:2-15
.
(02 February 2016)
Cancer stem cells in small cell lung cancer
Translational Lung Cancer Research
2016;
5
(1)
:16-25
.
(02 February 2016)
Treatment for small cell lung cancer, where are we now?—a review
Translational Lung Cancer Research
2016;
5
(1)
:26-38
.
(02 February 2016)
Small cell lung cancer (SCLC): no treatment advances in recent years
Translational Lung Cancer Research
2016;
5
(1)
:39-50
.
(02 February 2016)
Targeted drugs in small-cell lung cancer
Translational Lung Cancer Research
2016;
5
(1)
:51-70
.
(02 February 2016)
Original Article on Small Cell Lung Cancer1
Second-line therapy for small cell lung cancer: exploring the potential role of circulating tumor cells
Translational Lung Cancer Research
2016;
5
(1)
:71-77
.
(02 February 2016)
Editorial
Anti-vascular endothelial growth factor therapies at the crossroads: linifanib for non-small cell lung cancer
Translational Lung Cancer Research
2016;
5
(1)
:78-81
.
(02 February 2016)
Surgical controversies in mesothelioma: MesoVATS addresses the role of surgical debulking
Translational Lung Cancer Research
2016;
5
(1)
:82-84
.
(02 February 2016)
AZD9291 in TKI EGFR resistance in non-small cell lung cancer and the new concept of phase I trials
Translational Lung Cancer Research
2016;
5
(1)
:85-88
.
(02 February 2016)
Raising the bar for enthusiasm when looking at results of randomized phase II trials—the case of sunitinib in small-cell lung cancer
Translational Lung Cancer Research
2016;
5
(1)
:89-91
.
(02 February 2016)
AZD9291 in epidermal growth factor receptor inhibitor—resistant non-small-cell lung cancer
Translational Lung Cancer Research
2016;
5
(1)
:92-94
.
(02 February 2016)
Necitumumab for first-line treatment of advanced, squamous, non-small-cell lung cancer: a relevant step forward?
Translational Lung Cancer Research
2016;
5
(1)
:95-97
.
(02 February 2016)
Is epidermal growth factor receptor tyrosine kinase inhibitor in combination with cytotoxic chemotherapy a better treatment option for patients with EGFR-mutated non-small-cell lung cancer?
Translational Lung Cancer Research
2016;
5
(1)
:98-101
.
(02 February 2016)
Stereotactic ablative radiotherapy for early stage non-small cell lung cancer: a word of caution
Translational Lung Cancer Research
2016;
5
(1)
:102-105
.
(02 February 2016)
The continuing role of epidermal growth factor receptor tyrosine kinase inhibitors in advanced squamous cell carcinoma of the lung
Translational Lung Cancer Research
2016;
5
(1)
:106-109
.
(02 February 2016)
Afatinib in the treatment of squamous non-small cell lung cancer: a new frontier or an old mistake?
Translational Lung Cancer Research
2016;
5
(1)
:110-114
.
(02 February 2016)
Overall survival in non-small cell lung cancer—what is clinically meaningful?
Translational Lung Cancer Research
2016;
5
(1)
:115-119
.
(02 February 2016)
Review Article
PiggyBac transposon vectors: the tools of the human gene encoding
Translational Lung Cancer Research
2016;
5
(1)
:120-125
.
(02 February 2016)
Perspective
Dose escalation for unresectable locally advanced non-small cell lung cancer: end of the line?
Translational Lung Cancer Research
2016;
5
(1)
:126-133
.
(02 February 2016)
Commentary
Cranial irradiation in patients with EGFR-mutant non-small cell lung cancer brain metastases
Translational Lung Cancer Research
2016;
5
(1)
:134-137
.
(02 February 2016)
Immunotherapy in locally-advanced non-small cell lung cancer: releasing the brakes on consolidation?
Translational Lung Cancer Research
2016;
5
(1)
:138-142
.
(02 February 2016)
Letter to the Editor
Concomitant EGFR mutations/ALK rearrangements: beyond a simple dual target
Translational Lung Cancer Research
2016;
5
(1)
:143-144
.
(02 February 2016)
Case Report
Metachronous primary uterine cancer surgically resected during crizotinib treatment in a ALK-rearranged advanced lung adenocarcinoma
Translational Lung Cancer Research
2016;
5
(1)
:145-149
.
(02 February 2016)
Disclosure:
1. The series “Small Cell Lung Cancer” was commissioned by the editorial office, Translational Lung Cancer Research without any sponsorship or funding. Niki Karachaliou and Daniela Morales-Espinosa served as the unpaid Guest Editors for the series.
